vs
C4 Therapeutics, Inc.（CCCC）与Rent the Runway, Inc.（RENT）财务数据对比。点击上方公司名可切换其他公司
C4 Therapeutics, Inc.的季度营收约是Rent the Runway, Inc.的1.0倍（$11.0M vs $10.6M），Rent the Runway, Inc.净利率更高（721.7% vs -186.0%，领先907.7%），C4 Therapeutics, Inc.同比增速更快（112.8% vs 10.4%），过去两年C4 Therapeutics, Inc.的营收复合增速更高（90.4% vs 1.0%）
C4 Therapeutics是一家临床阶段生物制药企业，专注于开发靶向蛋白降解疗法，用于治疗癌症及其他存在重大未满足医疗需求的严重疾病。公司依托自有专利TORPEDO平台设计小分子降解剂清除致病蛋白，目前拥有多条肿瘤领域研发管线，并与头部制药企业达成战略合作。
Rent the Runway Inc.是总部位于纽约的美国电商平台，由珍妮弗·海曼与珍妮弗·弗莱斯于2009年11月创立，主打设计师品牌服饰与配饰的租赁、订阅以及购买服务，是设计师服饰共享租赁模式的开创平台之一。
CCCC vs RENT — 直观对比
营收规模更大
CCCC
是对方的1.0倍
$10.6M
营收增速更快
CCCC
高出102.4%
10.4%
净利率更高
RENT
高出907.7%
-186.0%
两年增速更快
CCCC
近两年复合增速
1.0%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $11.0M | $10.6M |
| 净利润 | $-20.5M | $76.5M |
| 毛利率 | — | -126.4% |
| 营业利润率 | -210.1% | -152.8% |
| 净利率 | -186.0% | 721.7% |
| 营收同比 | 112.8% | 10.4% |
| 净利润同比 | 40.7% | 504.8% |
| 每股收益（稀释后） | $-0.09 | $13.65 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCCCRENT
| Q4 25 | $11.0M | $10.6M | ||
| Q3 25 | $11.2M | $11.7M | ||
| Q2 25 | $6.5M | $7.6M | ||
| Q1 25 | $7.2M | $11.8M | ||
| Q4 24 | $5.2M | $9.6M | ||
| Q3 24 | $15.4M | $10.4M | ||
| Q2 24 | $12.0M | $8.9M | ||
| Q1 24 | $3.0M | $10.4M |
净利润CCCCRENT
| Q4 25 | $-20.5M | $76.5M | ||
| Q3 25 | $-32.2M | $-26.4M | ||
| Q2 25 | $-26.0M | $-26.1M | ||
| Q1 25 | $-26.3M | $-13.4M | ||
| Q4 24 | $-34.6M | $-18.9M | ||
| Q3 24 | $-24.7M | $-15.6M | ||
| Q2 24 | $-17.7M | $-22.0M | ||
| Q1 24 | $-28.4M | $-24.8M |
毛利率CCCCRENT
| Q4 25 | — | -126.4% | ||
| Q3 25 | — | -92.3% | ||
| Q2 25 | — | -168.4% | ||
| Q1 25 | — | -71.2% | ||
| Q4 24 | — | -122.9% | ||
| Q3 24 | — | -98.1% | ||
| Q2 24 | — | -131.5% | ||
| Q1 24 | — | -93.3% |
营业利润率CCCCRENT
| Q4 25 | -210.1% | -152.8% | ||
| Q3 25 | -306.4% | -171.8% | ||
| Q2 25 | -441.0% | -259.2% | ||
| Q1 25 | -402.9% | -65.3% | ||
| Q4 24 | -728.4% | -142.7% | ||
| Q3 24 | -183.9% | -92.3% | ||
| Q2 24 | -178.6% | -185.4% | ||
| Q1 24 | -1060.2% | -185.6% |
净利率CCCCRENT
| Q4 25 | -186.0% | 721.7% | ||
| Q3 25 | -286.4% | -225.6% | ||
| Q2 25 | -402.6% | -343.4% | ||
| Q1 25 | -363.7% | -113.6% | ||
| Q4 24 | -667.8% | -196.9% | ||
| Q3 24 | -160.6% | -150.0% | ||
| Q2 24 | -147.6% | -247.2% | ||
| Q1 24 | -933.2% | -238.5% |
每股收益（稀释后）CCCCRENT
| Q4 25 | $-0.09 | $13.65 | ||
| Q3 25 | $-0.44 | $-6.55 | ||
| Q2 25 | $-0.37 | $-6.58 | ||
| Q1 25 | $-0.37 | $-2.72 | ||
| Q4 24 | $-0.50 | $-4.70 | ||
| Q3 24 | $-0.35 | $-4.17 | ||
| Q2 24 | $-0.26 | $-6.03 | ||
| Q1 24 | $-0.41 | $-5.36 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | $50.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $256.6M | $-35.1M |
| 总资产 | $359.1M | $231.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CCCCRENT
| Q4 25 | $74.6M | $50.7M | ||
| Q3 25 | $58.8M | $43.6M | ||
| Q2 25 | $78.2M | $70.4M | ||
| Q1 25 | $51.3M | $77.4M | ||
| Q4 24 | $55.5M | $74.1M | ||
| Q3 24 | $59.6M | $76.6M | ||
| Q2 24 | $73.1M | $82.0M | ||
| Q1 24 | $89.7M | $84.0M |
总债务CCCCRENT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $340.6M | ||
| Q1 25 | — | $333.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CCCCRENT
| Q4 25 | $256.6M | $-35.1M | ||
| Q3 25 | $154.4M | $-232.1M | ||
| Q2 25 | $174.1M | $-207.1M | ||
| Q1 25 | $195.1M | $-182.5M | ||
| Q4 24 | $216.0M | $-171.2M | ||
| Q3 24 | $242.7M | $-154.5M | ||
| Q2 24 | $247.1M | $-141.3M | ||
| Q1 24 | $258.3M | $-122.3M |
总资产CCCCRENT
| Q4 25 | $359.1M | $231.0M | ||
| Q3 25 | $265.5M | $219.0M | ||
| Q2 25 | $296.5M | $245.3M | ||
| Q1 25 | $319.5M | $240.0M | ||
| Q4 24 | $349.6M | $251.6M | ||
| Q3 24 | $376.1M | $257.4M | ||
| Q2 24 | $381.1M | $278.4M | ||
| Q1 24 | $398.4M | $278.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.1M | $-1.4M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | -0.02× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CCCCRENT
| Q4 25 | $-22.1M | $-1.4M | ||
| Q3 25 | $-31.2M | $-10.5M | ||
| Q2 25 | $-12.1M | $8.3M | ||
| Q1 25 | $-33.3M | $1.4M | ||
| Q4 24 | $-17.9M | $4.7M | ||
| Q3 24 | $-24.1M | $2.2M | ||
| Q2 24 | $-5.0M | $4.6M | ||
| Q1 24 | $-18.1M | $-8.0M |
自由现金流CCCCRENT
| Q4 25 | — | — | ||
| Q3 25 | $-31.6M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-17.9M | — | ||
| Q3 24 | $-24.1M | — | ||
| Q2 24 | $-5.2M | — | ||
| Q1 24 | — | — |
自由现金流率CCCCRENT
| Q4 25 | — | — | ||
| Q3 25 | -281.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -346.5% | — | ||
| Q3 24 | -157.2% | — | ||
| Q2 24 | -43.1% | — | ||
| Q1 24 | — | — |
资本支出强度CCCCRENT
| Q4 25 | — | — | ||
| Q3 25 | 3.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 1.6% | — | ||
| Q1 24 | 0.0% | — |
现金转化率CCCCRENT
| Q4 25 | — | -0.02× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
